Position in OCGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,344,770
-$425,920 QoQ
Shares Held
3,505,398
-15.6% QoQ
Ownership
1.04%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GMT Capital Corp holds $123,541,469 across 6 Biotechnology names. OCGN ranks #2 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
581,000 | $109,838,050 | |
| 2 | OCGN |
Ocugen, Inc.
This page
|
3,505,398 | $6,344,770 | |
| 3 | TRVI |
Trevi Therapeutics, Inc.
|
317,700 | $3,790,161 | |
| 4 | PGEN |
Precigen, Inc.
|
668,830 | $2,588,372 | |
| 5 | FLNA |
Filana Therapeutics, Inc.
|
450,100 | $760,669 | |
| 6 | INO |
Inovio Pharmaceuticals, Inc.
|
126,119 | $219,447 |
All Filings in OCGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,344,770 | 3,505,398 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $6,770,690 | 4,153,798 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,029,184 | 4,153,798 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,932,581 | 4,153,798 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,976,241 | 2,454,958 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,435,318 | 2,454,958 | Shares | Sole | 2024-11-14 | |
| 2023-12-31 | $176,976 | 307,786 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,568,879 | 3,922,198 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,129,753 | 3,922,198 | Shares | Sole | 2023-08-10 | |
| No filing history on record for this holder in this stock. | ||||||